证券日报网讯 12月18日，晨曦航空在互动平台回答投资者提问时表示，公司的产品是可以用在商业航 天领域的，但是目前公司未开展该业务。 （文章来源：证券日报） ...

Group 1 - A total of 78 stocks in the A-share market experienced block trading today, with a total transaction value of 3.755 billion yuan [1] - The top three stocks by transaction value were Minsheng Bank (2.149 billion yuan), WuXi AppTec (430 million yuan), and Luxin Technology (119 million yuan) [1] - Among the stocks, 8 were traded at par, 3 at a premium, and 67 at a discount; the highest premium rates were for AVIC Optoelectronics (8.04%), Zhongke Shuguang (7.92%), and Haowei Group (2.07%) [1] Group 2 - The top buying amounts from institutional special seats were led by WuXi AppTec (251 million yuan) and Minsheng Bank (108 million yuan) [2] - The top selling amounts from institutional special seats included Jintian Titanium Industry (18.74 million yuan) and Huilong New Materials (9.97 million yuan) [2]

| 交易日期 | 证券代码 | 证券简称 | 成交价格 | 成交量 | 成交金额 | 买方营业部 | 卖方营业部 | | --- | --- | --- | --- | --- | --- | --- | --- | | | | | (元) | (万股/万份) | (万元) | | | | 2025-12-18 | 300581 | 晨曦航空 | 13.24 | 37.80 | 500.47 机构专用 | | 国信证券股份有限 | | | | | | | | | 公司陕西分公司 | | 2025-12-18 | 300581 | 晨曦航空 | 13.24 | 20.00 | 264.80 机构专用 | | 国信证券股份有限 | | | | | | | | | 公司陕西分公司 | 12月18日，晨曦航空大宗交易成交57.8万股，成交额765.27万元，占当日总成交额的2.78%，成交价 13.24元，较市场收盘价15.64元折价15.35%。 ...

格隆汇12月18日丨晨曦航空(300581.SZ)在投资者互动平台表示，公司的产品是可以用在商业航天领域 的，但是目前公司未开展该业务。 ...

证券日报网讯12月15日，晨曦航空（300581）在互动平台回答投资者提问时表示，截至2025年12月10日 公司股东户数约66000户。 ...

中国经济网北京12月15日讯 中国证监会陕西证监局于2025年12月12日公布《关于对西安晨曦航空科技 股份有限公司采取责令改正并对吴星宇、刘蓉采取出具警示函行政监管措施的决定》（陕证监措施字 〔2025〕47号）（以下简称《决定书》）。 行政监管措施显示，经查，西安晨曦航空科技股份有限公司（以下简称"晨曦航空"，300581.SZ）存在 收入确认存在跨期情形、应收票据未计提信用减值损失两项问题。 具体来看，晨曦航空2024年三季度对个别客户收入确认存在跨期情形，导致晨曦航空2024年三季报相关 数据披露不准确，不符合《企业会计准则第14号——收入》第十三条的规定。 根据《上市公司现场检查规则》（证监会公告〔2022〕21号）第二十一条和《办法》第五十二条规定， 陕西证监局决定对晨曦航空采取责令改正并对吴星宇、刘蓉采取出具警示函的行政监管措施。陕西证监 局要求相关人员应认真汲取教训，按照要求采取有效措施进行改正，并于收到决定书之日起三十日内向 陕西证监局提交书面整改报告。 深圳证券交易所创业板公司管理部于2025年12月12日下发《关于对西安晨曦航空科技股份有限公司、吴 星宇、刘蓉的监管函》（创业板监管函〔2 ...

西安晨曦航空科技股份有限公司 2024 年第三季度报告（更正后） 证券代码：300581 证券简称：晨曦航空 公告编号：2025-074 西安晨曦航空科技股份有限公司 1.董事会、监事会及董事、监事、高级管理人员保证季度报告的真实、准确、完整，不存在虚假记载、误导性陈述或重 大遗漏，并承担个别和连带的法律责任。 2.公司负责人、主管会计工作负责人及会计机构负责人(会计主管人员)声明：保证季度报告中财务信息的真实、准确、完 整。 3.第三季度报告是否经过审计 □是 否 1 西安晨曦航空科技股份有限公司 2024 年第三季度报告（更正后） 一、主要财务数据 （一） 主要会计数据和财务指标 2024 年第三季度报告（更正后） 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假记载、误 导性陈述或重大遗漏。 重要内容提示： 公司是否需追溯调整或重述以前年度会计数据 □是 否 | | 本报告期 | 本报告期比上年 | 年初至报告期末 | 年初至报告期末 | | --- | --- | --- | --- | --- | | | | 同期增减 | | 比上年同期增减 | | 营业收入（元） | 29,60 ...

证券代码：300581 证券简称：晨曦航空 公告编号：2025-073 现将相关事项公告如下： 一、概述 西安晨曦航空科技股份有限公司于 2025 年 12 月 12 日收到中国证券监督管 理委员会陕西监管局出具的《关于对西安晨曦航空科技股份有限公司采取责令改 正并对吴星宇、刘蓉采取出具警示函行政监管措施的决定》（陕证监措施字〔2025〕 47 号）（以下简称《决定书》），因公司 2024 年三季度对个别客户收入确认存在 跨期情形，导致公司 2024 年三季度相关数据披露不准确，不符合《企业会计准 则第 14 号——收入》第十三条的规定。根据《决定书》要求，现就公司于 2024 年 10 月 29 日在巨潮资讯网（http://www.cninfo.com.cn）披露的《西安晨曦航空 科技股份有限公司 2024 年第三季度报告》（公告编号：2024-082）中的部分内容 进行更正。具体如下： 二、本次更正对公司财务状况和经营成果的影响 西安晨曦航空科技股份有限公司 关于 2024 年第三季度报告更正的公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完 整，没有虚假记载、误导性陈述或重大遗漏。 特别提 ...

Group 1 - Shouyao Holdings is planning to issue H-shares and list on the Hong Kong Stock Exchange, with discussions ongoing with intermediaries regarding the specifics of the listing [1] - Jiangsu Guoxin's subsidiary, Guoxin Mazhou, has completed the trial operation of a 1000MW coal-fired power unit, which is set to officially commence operations on December 12, 2025 [2] - Yuekang Pharmaceutical's mRNA tumor vaccine has received clinical trial approval from the National Medical Products Administration for treating advanced solid tumors [3] Group 2 - Dongli New Science plans to invest 666 million yuan in the restructuring of SAIC Hongyan, acquiring approximately 14.66% equity post-restructuring [4] - Longsheng Technology is set to invest approximately 350 million yuan in the establishment of an intelligent robot innovation center in Wuxi [5] - Shangwei Co. has received a government subsidy of 2.212 million yuan, which accounts for 13.53% of its audited net profit for 2024 [6] Group 3 - Anglikang has received drug registration certificates for Diclofenac Sodium Enteric-Coated Tablets and approval for a supplemental application for Sacubitril/Valsartan Sodium Tablets [7] - Guangzhou Development has received acceptance notices for the registration of 8 billion yuan in medium-term notes and 6 billion yuan in short-term financing bonds [8] - Kebo Da plans to increase capital by 21.2 million euros (approximately 174 million yuan) in its wholly-owned subsidiary in Germany [9][10] Group 4 - Changguang Huaxin has received a total of 11.6672 million yuan in government subsidies, including 8.0552 million yuan related to income [11] - Haizheng Pharmaceutical's subsidiary has received a European Pharmacopoeia suitability certificate for its raw material [12] - Qianjin Pharmaceutical's subsidiary has received a drug registration certificate for Lurasidone Hydrochloride Tablets, used for treating schizophrenia [13] Group 5 - Daimai Co. has received a warning letter from the Shanghai Securities Regulatory Bureau due to failure to timely disclose a significant event related to a fire incident [14] - ST Changyao's subsidiary has recently ceased production due to financial difficulties and competitive pressures in the photovoltaic industry [15] - Guodian Power is investing in the construction of a 2×1000MW expansion project at the Ganbi Power Plant, with a total dynamic investment of 7.218 billion yuan [16] Group 6 - Kaichuang International's subsidiary has completed the handover of a tuna purse seine vessel, expected to be operational by 2026 [16] - Tieke Rail plans to sign an energy management agreement for a distributed photovoltaic project, which is expected to save approximately 1.441 million yuan in electricity costs over 25 years [18] - Bailian Co. plans to sign a land compensation agreement with Friendship Logistics, with a total compensation of 103 million yuan [19] Group 7 - Dayu Water-saving's subsidiary has been pre-awarded two high-standard farmland construction projects, with total expected amounts of 137 million yuan and 135 million yuan respectively [20] - Tianma Technology reported a total eel output of approximately 1197.15 tons in November, with sales prices ranging from 53,000 yuan/ton to 89,000 yuan/ton [21] - Guorui Technology's subsidiary has been shortlisted for the GXLF project with a bid of 76 million yuan [22] Group 8 - Qingdao Food's deputy general manager has resigned for personal reasons [23] - Guosheng Zhike plans to use up to 900 million yuan of idle funds for cash management [24] - Guodian Nanrui plans to use up to 23 billion yuan of idle funds for entrusted wealth management [25] Group 9 - Jiahuan Energy plans to merge its wholly-owned subsidiary, Zhejiang Jiahuan Hydrogen Peroxide Co., Ltd., through an overall absorption merger [26] - Ganyue Expressway reported vehicle toll service revenue of 309 million yuan for November [27] - Jinling Hotel's chairman has resigned due to work changes [28] Group 10 - Lisheng Pharmaceutical's subsidiary has received drug registration certificates for Apremilast Tablets [29] - Baotai has received a positive opinion from the European Medicines Agency for Gotenfia® for various inflammatory conditions [30] - ST Zhisheng has been awarded a smart city governance project with a bid amount of 104 million yuan [31] Group 11 - Chenxi Aviation and its related personnel have received administrative regulatory measures from the Shaanxi Securities Regulatory Bureau due to financial reporting issues [32] - Portong Medical has appointed Xia Canglan as the new deputy general manager [33] - Maide Medical plans to repurchase shares with a total amount between 20 million and 40 million yuan [34] Group 12 - Jimin Health plans to establish a joint venture with a total investment of 600 million yuan, focusing on AI and software development [35] - Beilu Pharmaceutical has received a drug registration certificate for Pioglitazone Metformin Tablets [36] - Hainan Mining plans to entrust the overall management of the Shiluo Iron Mine to a construction company for three years, with a total contract amount of approximately 818 million yuan [38] Group 13 - Huiyu Pharmaceutical has received a drug registration certificate for Nicardipine Hydrochloride Injection [39] - Baoland has received a government subsidy of 10 million yuan related to income [40] - Qingdao Port has terminated the acquisition of 100% equity in an oil company and 50% equity in Rizhao Shihua due to regulatory concerns [41]

晨曦航空12月12日公告，公司于今日收到陕西证监局下发的《关于对西安晨曦航空科技股份有限公司采 取责令改正并对吴星宇、刘蓉采取出具警示函行政监管措施的决定》。经查，公司存在收入确认存在跨 期情形、应收票据未计提信用减值损失等问题，导致公司相关财务数据披露不准确。董事长兼总经理吴 星宇、时任财务负责人刘蓉对上述违规事项负有主要责任。陕西证监局决定对公司采取责令整改并对吴 星宇、刘蓉采取出具警示函的行政监管措施。 ...